论文部分内容阅读
膀胱癌是我国泌尿系统最常见的恶性肿瘤之一,具有恶性程度高、复发率高、生存率低等特点~([1])。浸润性膀胱癌其治疗首选根治性膀胱切除术,但手术有较大的创伤,患者术后恢复慢,生活质量明显下降。部分年龄较大的晚期膀胱癌患者因基础疾病较多,存在手术禁忌症而不能耐受手术。随着经尿道膀胱肿瘤电切术(transurethral resection of bladder tumor,TURBT)、介入技术、化疗技术的不断完善,已有在保
Bladder cancer is one of the most common malignant tumors in our urinary system. It has the characteristics of high malignancy, high recurrence rate and low survival rate ([1]). The treatment of invasive bladder cancer is the first choice of radical cystectomy, but surgery has a greater trauma, postoperative recovery slow, quality of life decreased significantly. Some older patients with advanced bladder cancer due to more underlying diseases, there are surgical contraindications and can not tolerate surgery. With the transurethral resection of bladder tumor (TURBT), interventional techniques, chemotherapy technology continues to improve, there is Paul